3[2]Varma S,McElnay JC,Hughes CM,et al.Pharmaceutical care of elderly congestive heart failure patients:Interventions and outcomes[J].Pharmacoth,1999,19:860-869.
4[3]Rector T,Kubo S,Cohn J.Patient' s Self-assesment of their congestive heart failure.Part 2:content,reliability and validity of a new measure,the Minnesota Living with Heart Failure Questionnnaire[J].Heart Failure,1987,3:198-209.
5[4]Vermeire E,Hearnshaw H,Van Royen P,et al.Patient adherence to treatment:three decades of research.A comprehensive review[J].J Clin Pharm Ther,2001,26:331-342.
6[5]Chali JK,Kadaki S,Cooper R,et al.recipitating factors leading to decompensation of heart failure:trials among urban blacks[J].Arch Intern Med,1988,148:2014-2016.
7[6]Kosseim LM,Pifer AE,Zimmer R.Effective management of complex heart failure[J].Postgrad Med,1999,105:17-24.
8[7]Mary Kodiath,Ann Kelly,Martha Shively.Improving quality of life in patients with heart failure[J].Journal of cardiovascular nursing,2005,20(1):42-48.
8Colln$-McNeil J.Psychosocial characteristics and cardiovascular Risk in African Americans with diabetes[J].Arch PsychiatrNu rs, 2006,20(5) = 226-255.
9Healy WL, Iorio R, Ko J, et al. Impact of cost reduction programson short-term patient outcome and hospital cost of total knee arthyoplasty. J Bone Joint Surg Am,2002,84 (3) :348-353.
10Higgins JP, Thompson SG. Quantifying heterogeneity in a meta- analysis[J]. Star Med,2002,21 ( 11): 1539-1558.
